I disagree.
I'm expecting the past 4 months there has been dialogue with the FDA as was forecast in the announcement of the previous FDA meeting and the endpoints are now agreed.
I don't see a reason why the type c meeting is anything other than a formality.
Why would you request one if it wasn't?
Ann: Type C Meeting granted by FDA for Phelan-McDermid syndrome, page-17
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$13.70 |
Change
1.160(9.25%) |
Mkt cap ! $1.729B | |||
| Open | High | Low | Value | Volume |
| $12.96 | $14.00 | $12.91 | $13.22M | 962.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 580 | $13.70 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.72 | 394 | 5 |
View Market Depth
| Last trade - 14.37pm 26/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |